Early-stage BAP1-associated malignancies

Clinical trials for Early-stage BAP1-associated malignancies explained in plain language.

Never miss a new study

Get alerted when new Early-stage BAP1-associated malignancies trials appear

Sign up with your email to follow new studies for Early-stage BAP1-associated malignancies, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet finished but already full! 1

New hope for rare cancer: oral pill targets early mesothelioma in High-Risk patients

Disease control Recruiting now

This study tests an oral medication (decitabine/cedazuridine) in people with BAP1 gene mutations who have early-stage mesothelioma that is not yet causing symptoms. The goal is to see if the drug can stop the cancer from growing or shrink it. About 9 participants will receive tre…

Matched conditions: EARLY-STAGE BAP1-ASSOCIATED MALIGNANCIES

Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Sep 05, 2026 00:00 UTC

Early-stage BAP1-associated malignancies

Get alerted when new Early-stage BAP1-associated malignancies trials appear

New hope for rare cancer: oral pill targets early mesothelioma in High-Risk patients